Conference Coverage

Cancer Among Women Treated in the Veterans Affairs Health Care System

Abstract: 2018 AVAHO Meeting


 

Background: The Veterans Affairs (VA) healthcare system is a high-volume provider of cancer care. Women are the fastest growing patient population using VA health care services. Quantifying the types of cancers diagnosed among women in the VA is a critical step toward identifying needed healthcare resources for women veterans with cancer.

Methods: We obtained data from the VA Central Cancer Registry for cancers newly diagnosed in calendar year 2010. Our analysis was limited to women diagnosed with invasive cancers (eg, stages I-IV) between January 1, 2010 and December 31, 2010 in the VA healthcare system. We evaluated frequency distributions of incident cancer diagnoses by primary anatomical site, race, and geographic region. For commonly occurring cancers, we reported distribution by stage.

Results: We identified 1,330 women diagnosed with invasive cancer in the VA healthcare system in 2010. The most commonly diagnosed cancer among women veterans was breast (30%), followed by cancers of the respiratory (16%), gastrointestinal (12%), and gynecological systems (12%). The most commonly diagnosed cancers were similar for white and minority women, except white women were significantly more likely to be diagnosed with respiratory cancers (P < .01) and minority women were significantly more likely to be diagnosed with gastrointestinal cancers (P = .03).

Conclusions: Understanding cancer incidence among women veterans is important for healthcare resource planning. While cancer incidence among women using the VA healthcare system is similar to US civilian women, the geographic dispersion and small incidence relative to male cancers raises challenges for high-quality, well-coordinated cancer care within the VA.

Recommended Reading

Elder Patients With Diabetes at Higher Risk for Cancer Surgery
AVAHO
Abstracts Presented at the 2017 AVAHO Annual Meeting (TEXT)
AVAHO
Uncovering Clues That Explain the Ototoxicity of Cisplatin
AVAHO
ACS: Screen for colon cancer at 45
AVAHO
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
AVAHO
Prostate cancer risk before age 55 higher for black men
AVAHO
Testicular Pain Leads to a Rare Diagnosis
AVAHO
Federal Health Care Data Trends: Oncology
AVAHO
FDA warns against azithromycin in blood or lymph node cancers
AVAHO
Use of Mobile Messaging System for Self-Management of Chemotherapy Symptoms in Patients With Advanced Cancer
AVAHO